Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Journal of Neurology|November 6, 2013
Risk factors and prodromal markers and the development of Parkinson's diseaseStefanie Lerche, Klaus Seppi, Stefanie Behnke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2017
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohortsAndrea Pilotto, Sebastian Heinzel, Ulrike Suenkel, et al.
Neurobiology of Aging|October 14, 2021
Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's diseaseDaniel Charissé, Guray Erus, Raymond Pomponio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 25, 2025
A network perspective on cognition in individuals with Parkinson's diseaseDaniel Scharfenberg, Elke Kalbe, Monika Balzer-Geldsetzer, et al.
NPJ Parkinson'S Disease|April 6, 2026
Temporal dynamics of cognitive functioning in people with Parkinson's diseaseDaniel Scharfenberg, Elke Kalbe, Anja Ophey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's diseaseDaniela Berg, Stefanie Behnke, Klaus Seppi, et al.
Journal of Neuromuscular Diseases|May 24, 2020
Confirmation of TACO1 as a Leigh Syndrome Disease Gene in Two Additional FamiliesYavuz Oktay, Serdal Güngör, Lena Zeltner, et al.
Neurology|October 23, 2020
Phenylalanine Effects on Brain Function in Adult PhenylketonuriaAndrea Pilotto, Carl M Zipser, Edytha Leks, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 8, 2018
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)Yuliya Stankevich, Ulrike Lueken, Monika Balzer-Geldsetzer, et al.
Parkinsonism & Related Disorders|August 21, 2021
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyRobert Lillig, Anja Ophey, Jörg B Schulz, et al.
Pageof 13